Biological Drugs to 2020

Wednesday, December 6, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2017 /PRNewswire/ -- In recent years, the number of biological drugs in development and reaching the marketplace

has increased significantly. The clinical application of these drugs is sometimes limited by a lack of desirable attributes for adequate absorption or distribution.

Read the full report: https://www.reportlinker.com/p05232375

So

it's critical to formulate these drugs into safe, stable and efficacious delivery systems. Because these drugs face formidable enzymatic and penetration barriers when administered orally, peptide and protein drugs continue to be developed almost exclusively for parenteral administration.

The growth of biological drug products is having a significant effect on the way drugs and devices are developed. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies. Therapeutic Biological Drugs to 2020 is a comprehensive analysis of these factors and market segments.

What You Will Learn

  • What are the currently approved biological drugs; their dosing, host system, indication(s); what is their as-supplied configuration?
  • What are the key market segments for biological drugs; what are the market dynamics and market demographics?
  • What are the therapeutic demand drivers and commercial devices in key product segments?
  • What are the supply chain dynamics, technologies and market development issues?
  • How big is the market? How is it growing? What will it look like in 2020?
  • Who are the leading biological drug suppliers, their product development activities, business strategies, and corporate alliances and affiliations?
  • What are the significant economic, technology, and regulatory factors affecting the market for biological drugs?

Read the full report: https://www.reportlinker.com/p05232375

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

 

View original content:http://www.prnewswire.com/news-releases/biological-drugs-to-2020-300567290.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store